Planet Green Holdings Q4 EPS $(0.09) Up From $(0.34) YoY, Sales $9.83M Up From $6.97M YoY
Trade with 70% Backtested Accuracy
Analyst Views on PLAG
About PLAG
About the author

- Delisting Risk Notification: On December 8, 2025, Planet Green Holdings Corp. received a notice from the NYSE regarding its non-compliance due to a shareholder deficit of $573,528 as of September 30, 2025, and losses over the last five fiscal years, indicating significant financial distress.
- Compliance Plan Requirement: The company must submit a plan by January 7, 2026, detailing actions to regain compliance by June 8, 2027, highlighting the urgency and uncertainty surrounding its future operations.
- Continued Listing Conditions: During the 18-month cure period, the company's common stock will remain listed and traded on the NYSE, contingent upon adherence to other applicable listing rules, emphasizing the need for immediate corrective measures to maintain market confidence.
- Diversified Business Background: Despite facing financial challenges, Planet Green operates a diversified portfolio in China and Canada, including consumer products, chemical products, and online advertising, suggesting potential value in its business model if compliance is achieved.

- Successful Product Launch: Planet Green's subsidiary Hubei Shengsili Biotechnology Co., Ltd. debuted its Black Gold Series tea products, attracting numerous tea distributors and showcasing strong market potential and consumer interest.
- Fusion of Tradition and Modernity: The Black Gold Series, rooted in a 400-year tea-making tradition, tailors to contemporary consumer tastes, aiming to convey traditional Chinese black tea culture to a new generation and enhance brand influence.
- Positive Market Feedback: Attendees at the launch event expressed enthusiastic feedback regarding the quality, aroma, and market potential of the new products, indicating strong purchase interest and suggesting a promising market outlook.
- Production and Distribution Expansion: Hubei Shengsili plans to accelerate production and expand distribution channels to meet the growing market demand for the Black Gold Series, further solidifying its position in the tea market.

Precision BioSciences Stock Surge: Shares of Precision BioSciences rose 10.8% to $5.58 in pre-market trading after the U.S. FDA cleared its investigational new drug application for PBGENE-HBV, aimed at treating chronic hepatitis B.
Pre-Market Trading Highlights: Several stocks experienced significant movements in pre-market trading, with notable gainers including NanoVibronix (up 42.3%) and Lytus Technologies (up 36.7%), while losers included Fold Holdings (down 18.8%) and Incyte Corporation (down 15.3%).
Earnings Report: Planet Green Holdings reported a second-quarter 2024 earnings per share of -29 cents and revenue of $1.95 million.
Automated Coverage: InvestorPlace Earnings utilizes TradeSmith data to provide automated coverage of quarterly earnings reports, highlighting key financial figures without human intervention.








